These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22418780)

  • 1. Intraocular activation of angiogenic and inflammatory pathways in uveal melanoma.
    Dunavoelgyi R; Funk M; Sacu S; Georgopoulos M; Zlabinger G; Zehetmayer M; Schmidt-Erfurth U
    Retina; 2012 Jul; 32(7):1373-84. PubMed ID: 22418780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of 12 cytokines in aqueous humour of uveal melanoma before and after combined Ruthenium-106 brachytherapy and transpupillary thermotherapy.
    Lee CS; Jun IH; Kim TI; Byeon SH; Koh HJ; Lee SC
    Acta Ophthalmol; 2012 Jun; 90(4):e314-20. PubMed ID: 22429778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.
    Nagarkatti-Gude N; Bronkhorst IH; van Duinen SG; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6748-55. PubMed ID: 22930720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.
    Usui Y; Tsubota K; Agawa T; Ueda S; Umazume K; Okunuki Y; Kezuka T; Yamakawa N; Goto H
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):393-399. PubMed ID: 27878431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma.
    Usui Y; Wakabayashi Y; Okunuki Y; Kimura K; Tajima K; Matsuda R; Ueda S; Ma J; Nagai T; Mori H; Kezuka T; Nagao T; Goto H
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5395-402. PubMed ID: 22789925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity.
    Sato T; Kusaka S; Shimojo H; Fujikado T
    Ophthalmology; 2009 Nov; 116(11):2165-9. PubMed ID: 19700197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion.
    Lee WJ; Kang MH; Seong M; Cho HY
    Br J Ophthalmol; 2012 Nov; 96(11):1426-30. PubMed ID: 22930681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine concentration in aqueous humor of eyes with diabetic macular edema.
    Jonas JB; Jonas RA; Neumaier M; Findeisen P
    Retina; 2012; 32(10):2150-7. PubMed ID: 22617833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory.
    Canovas D; Rennie IG; Nichols CE; Sisley K
    Cancer; 2008 Apr; 112(8):1787-94. PubMed ID: 18300240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor a in eyes with uveal melanoma.
    Missotten GS; Notting IC; Schlingemann RO; Zijlmans HJ; Lau C; Eilers PH; Keunen JE; Jager MJ
    Arch Ophthalmol; 2006 Oct; 124(10):1428-34. PubMed ID: 17030710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.
    Schoenberger SD; Kim SJ; Sheng J; Rezaei KA; Lalezary M; Cherney E
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5906-11. PubMed ID: 22871833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous increases in multiple proinflammatory cytokines in the aqueous humor in pseudophakic glaucomatous eyes.
    Inoue T; Kawaji T; Inatani M; Kameda T; Yoshimura N; Tanihara H
    J Cataract Refract Surg; 2012 Aug; 38(8):1389-97. PubMed ID: 22814044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y; Gao S; Zhu Y; Shen X
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines concentrations in aqueous humor of eyes with uveal melanoma.
    Cheng Y; Feng J; Zhu X; Liang J
    Medicine (Baltimore); 2019 Feb; 98(5):e14030. PubMed ID: 30702560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.
    Ly LV; Bronkhorst IH; van Beelen E; Vrolijk J; Taylor AW; Versluis M; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5445-51. PubMed ID: 20538984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.
    Boyd SR; Tan D; Bunce C; Gittos A; Neale MH; Hungerford JL; Charnock-Jones S; Cree IA
    Br J Ophthalmol; 2002 Apr; 86(4):448-52. PubMed ID: 11914216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of soluble CD14 and cytokine levels on diabetic macular edema and visual acuity.
    Umazume K; Usui Y; Wakabayashi Y; Okunuki Y; Kezuka T; Goto H
    Retina; 2013 May; 33(5):1020-5. PubMed ID: 23095769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of inflammatory immune mediators in vitreous from pseudophakic eyes.
    Jakobsson G; Sundelin K; Zetterberg H; Zetterberg M
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3407-14. PubMed ID: 26024125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy.
    Schoenberger SD; Kim SJ; Shah R; Sheng J; Cherney E
    JAMA Ophthalmol; 2014 Jan; 132(1):32-7. PubMed ID: 24336915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.